
Covid-19
Company in the news
Top Glove screens Malaysia workers after positive Covid-19 results
Top Glove Corp., the world’s biggest rubber-glove maker, is screening more workers after some of them at four of its Malaysian factories tested positive for the coronavirus.
Covid-19
Singapore to require all inbound travellers take virus tests
Singapore will require all inbound travellers to take a Covid test upon arrival in the city-state from Jan 25 amid a resurgence of cases globally, the Ministry of Health said in a statement.
US politics
Here are the major parts of the US$1.9 trillion Biden relief plan
President-elect Joe Biden’s US$1.9 trillion Covid-19 relief plan is designed to both pump money into the economy and contain the coronavirus pandemic.
JOBS
As Covid-19 hits job market, HR firms roll up sleeves
Graduation is typically a time for hope in the future, as the new graduates ponder the future’s infinite possibilities.
Disruption and Digitalisation

Which companies will dominate in the future decades? 2021 will define the answer
Christmas Day, 2050, and it’s strange watching the family unwrap their presents.
Disruption and Digitalisation

Logistics lessons from the pandemic: How businesses can adapt
The coronavirus has disrupted the world in an unprecedented manner.
Global Economy

A fragile recovery in 2021
By the end of 2020, financial markets — mostly in the United States — had reached new highs, owing to hopes that the numerous Covid-19 vaccines would create the conditions for a rapid V-shaped reco
Funds

Vaccine ETFs outperform Nasdaq and S&P500; offer diversified exposure to Covid
Much has been written about the impact of Covid-19 on market behaviour and market psychology.
Results
Lian Beng reports 5.2% lower earnings of $17.6 mil for 1H21 due to circuit breaker measures, foreign workforce disruptions
Homegrown building construction and property development company Lian Beng Group has registered earnings of $17.6 million for the 1HFY2021 ended November, 5.2% lower than earnings of $18.6 million
Covid-19
China vaccine's low efficacy due to high-risk group, says Sinovac CEO
Chinese vaccine developer Sinovac Biotech Ltd.